Evidence map›Paper›PMID 31200275›Full record

ReviewCurrent opinion in biotechnology2019

Caged luciferins for bioluminescent activity-based sensing.

Timothy A Su, Kevin J Bruemmer, Christopher J Chang

Open access · bronzeAbstract readReview
In one paragraph

Review in Current opinion in biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 67 citations in OpenAlex.

  1. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Luminescent Assay for the Screening of SARS-CoV-2 MChembiochem : a European journal of chemical biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Timothy A SuDepartment of Chemistry, University of California, Berkeley, CA 94720, United States.
Kevin J BruemmerDepartment of Chemistry, University of California, Berkeley, CA 94720, United States.
Christopher J ChangDepartment of Chemistry, University of California, Berkeley, CA 94720, United States; Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, United States; Helen Wills Neuroscience Institute, University of California, Berkeley, CA 94720, United States; Howard Hughes Medical Institute, University of California, Berkeley, California 94720, United States.
University of California, Berkeley · USHoward Hughes Medical Institute · US

Funding

Training CoreP42ES004705 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI HUBBARD, ALAN E · 1987 to 2025
$74.6M
Molecular Imaging Probes To Study Redox BiologyR01GM079465 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Christopher J. Chang · 2006 to 2026
$7.8M
Univ of Calif Berkeley Chemistry-Biology Interface ProgramT32GM066698 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, CHRISTOPHER J., FRANCIS, MATTHEW B · 2004 to 2023
$7.5M
Chemical Probes to Study Formaldehyde BiologyR01ES028096 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Christopher J. Chang · 2017 to 2026
$4.1M
Targeted Copper-based Therapeutics and ProbesF32GM122248 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI SU, TIMOTHY · 2017 to 2019
$140k
Howard Hughes Medical InstituteNIEHS NIH HHS P42 ES004705NIEHS NIH HHS R01 ES028096NIGMS NIH HHS F32 GM122248NIGMS NIH HHS R01 GM079465NIGMS NIH HHS T32 GM066698
6 · The paper itself

Abstract

Bioluminescence imaging is a powerful modality for in vivo imaging owing to its low background and high signal-to-noise ratio. Because bioluminescent emission occurs only upon the catalytic reaction between the luciferase enzyme and its luciferin substrate, caging luciferins with analyte-reactive triggers offers a general approach for activity-based sensing of specific biochemical processes in living systems across cell, tissue, and animal models. In this review, we summarize recent efforts in the development of synthetic caged luciferins for tracking enzyme, small molecule, and metal ion activity and their contributions to physiological and pathological processes.

Indexed as

Luminescent MeasurementsAnimalsLuciferasesLuciferases

Identifiers

PMID31200275
PMCPMC6891152
OpenAlexW2949527438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.